跳至主要内容
临床试验/NCT06126198
NCT06126198已完成不适用

1 Hz RTMS Feasibility Study on Adolescent Treatment Resistant Major Depression

Uppsala University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Inclusion rate -

研究概览

简要总结

This is an open-label study, in which all participants receives an active treatment with repetitive transcranial magnetic stimulation (rTMS) according to clinical protocol. The aim with this pilotstudy is to investigate the feasibility to perform a trial of low-frequency rTMS on treatment-resistant depression in adolescents. The study includes adolescents 13-19 years old, with average to severe depression.

详细描述

The intervention follows the identical clinical procedure used for adults. Initially, the resting motor threshold will be determined by stimulation over the motor cortex, by finding the minimal intensity that produces a motor response in the corresponding distal wrist muscles. The rTMS will be delivered with a powerMAG research ppTMS stimulator (Mag & More), and a figure-of -eight coil, PMD70-pCool (Mag & More). The intervention is within the intended use of this CE-marked medical device. The research participants will receive 1Hz rTMS with daily sessions on 20-30 consecutive week days. The magnetic pulses will be applied at 120% of the resting motor threshold with a figure-of-eight coil at a 45 degree angle towards the midline. The 1Hz rTMS protocol is applied 6 trains of 1-min duration separated by 30-sec inter-train "off" periods over the right DLPFC (F4 site 5 according to the10-20 system). The total duration of one 1 Hz rTMS session is 8 min 30 s.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
13 Years 至 19 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Informed consent from parents and legal guardian
  • •Age 13-19 years
  • •Diagnosis of uni- or bipolar depression verified through a Mini International Neuropsychiatric Interview for children and adolescents (MINI-KID)
  • •Treatment with at least two SSRIs at an adequate dose for at least 8 weeks

排除标准

  • •Epilepsy or medical history of seizures
  • •Conductive ferromagnetic or other magnetic sensitive metals implanted in the head or within 30 cm of the treatment coil
  • •Implanted device that is activated or controlled in any way by physiological signals
  • •Implanted medication pumps
  • •Intracardiac lines (even if removed)
  • •Active substance use disorder
  • •Treatment with any medication that could lower the threshold for seizures
  • •Usage of benzodiazepines both as prescribed drug and illegal use
  • •Any condition that seriously increases the risk of non-compliance or loss of follow-up

研究组 & 干预措施

Active treatment

Experimental

Active treatment with Repetitive Transcranial Magnetic Stimulation (rTMS) according to clinical protocol.

干预措施: Repetitive Transcranial Magnetic Stimulation (rTMS) (Device)

结局指标

主要结局

Inclusion rate -

时间窗: two years

Participant inclusion during the course of the study

Attrition rate

时间窗: two years

Participant drop-off during the course of the study

次要结局

  • CGAS (Children's Global Assessment Scale) score(4 weeks, 6 weeks)
  • MADRS (Montgomery and Asberg Depression Rating Scale) score(at Baseline, 4 weeks, 6 weeks)

研究者

发起方
Uppsala University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验